Matsuki Eri, Miyakawa Yoshitaka, Okamoto Shinichiro
Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Blood Coagul Fibrinolysis. 2011 Apr;22(3):227-30. doi: 10.1097/MBC.0b013e328343f928.
Hereditary factor XII (FXII) deficiency is a clinically asymptomatic, autosomal recessive disorder. We have experienced a rare case of FXII deficiency in a patient previously diagnosed with hereditary spastic paraplegia (HSP). The patient had no major bleeding episodes and presented with a prolonged activated partial thromboplastin time (APTT) at hospital administration. Sequencing of the FXII gene revealed a novel missense mutation at exon 4 that substitutes arginine 84 to proline (R84P). To elucidate the molecular mechanism of FXII deficiency, wild-type and R84P mutant FXII cDNA were transiently expressed in CHO cells. We found that secretion but not synthesis of R84P mutant protein was markedly reduced compared to wild type. These results indicated that R84P mutation might impair the intracellular transport or secretion of FXII protein of the cells and could be a useful tool for the analysis of structure-function relationship and intracellular protein transport of FXII protein in the future.
遗传性凝血因子XII(FXII)缺乏症是一种临床无症状的常染色体隐性疾病。我们遇到过一例罕见的FXII缺乏症患者,该患者先前被诊断患有遗传性痉挛性截瘫(HSP)。该患者无重大出血事件,在入院时活化部分凝血活酶时间(APTT)延长。FXII基因测序显示外显子4有一个新的错义突变,将精氨酸84替换为脯氨酸(R84P)。为了阐明FXII缺乏的分子机制,野生型和R84P突变型FXII cDNA在CHO细胞中瞬时表达。我们发现,与野生型相比,R84P突变蛋白的分泌而非合成明显减少。这些结果表明,R84P突变可能损害细胞内FXII蛋白的转运或分泌,并且在未来可能成为分析FXII蛋白结构-功能关系和细胞内蛋白转运的有用工具。